Document is current
Any future updates will be listed below
-
Authors
Gupta, Milli
Bredenoord, Albert J. https://orcid.org/0000-0001-5918-2062
-
Funding
Funding for this research was provided by:
ZonMw (91718300)
- License Information
-
More Information
Article History
Received: 11 December 2023
Accepted: 19 December 2023
First Online: 6 January 2024
Declarations
:
: MG participates on advisory boards and receives speaker fees from Sanofi Regeneron, AVIR Pharma, Bausch Health, Takeda, and Astra Zeneca. AJB received research funding from Norgine, Dr Falk Pharma, Thelial, Sanofi/Regeneron, and SST and received speaker and/or consulting fees from Laborie, Medtronic, BMS, Dr. Falk Pharma, Reckitt, Aqilion, Eupraxia, Alimentiv, Sanofi/Regeneron, and AstraZeneca.
Free to read: This content has been made available to all.
